Noble Wealth Management PBC Buys New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Noble Wealth Management PBC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 306 shares of the healthcare conglomerate’s stock, valued at approximately $155,000.

Several other hedge funds also recently modified their holdings of the stock. Jmac Enterprises LLC lifted its holdings in shares of UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock valued at $481,000 after purchasing an additional 18 shares during the last quarter. Wallace Capital Management Inc. raised its position in shares of UnitedHealth Group by 0.9% in the 3rd quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after purchasing an additional 19 shares during the last quarter. Western Pacific Wealth Management LP lifted its stake in shares of UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after buying an additional 19 shares in the last quarter. JNBA Financial Advisors increased its position in shares of UnitedHealth Group by 0.4% during the third quarter. JNBA Financial Advisors now owns 4,686 shares of the healthcare conglomerate’s stock valued at $2,740,000 after acquiring an additional 20 shares in the last quarter. Finally, Paragon Capital Management LLC lifted its position in UnitedHealth Group by 2.9% in the 3rd quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock valued at $422,000 after acquiring an additional 20 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on UNH shares. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Oppenheimer raised their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $474.95 on Friday. The stock’s 50-day simple moving average is $516.59 and its 200-day simple moving average is $557.04. The company has a market capitalization of $437.09 billion, a price-to-earnings ratio of 30.64, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.77%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.